HLF and neoplasm: Recent studies also revealed that hepatic leukemia factor (HLF) can promote chemoresistance in TNBC by inhibiting ferroptosis through the regulation of the IL-6/TGF-β1 signaling axis, ultimately facilitating tumor progression and metastasis (20).